Firms Vie To Be Lead Counsel In Telik Fraud Case

No fewer than eight groups of plaintiffs suing a biopharmaceutical company and several prominent financial companies for securities fraud on Monday asked to have their cases consolidated, with each group seeking...

Already a subscriber? Click here to view full article